The U.S Supreme court declined to hear Apotex's request for a rehearing on patent litigation with Abott Laboratories over the epilepsy drug Depakote (Divalproex Sodium) and in result ending the decade long litigation in Abott's favour.
Abott filed a petition for writ of certiorari in January 2008, after losing the case in October 2007 and having his request for a rehearing denied in the US court of Appeals for Federal Circuit.
The Federal circuit decision can be read here.
No comments:
Post a Comment